CYTONIR

Research in the field of development of new pharmacological medications.

The CytoNIR Company is part of the Medical-Biological Research-Industrial Complex CYTOMED, and heads the research activity of Cytomed.

The main focus of CytoNIR’s research activity is on seeking out and developing new peptide medications, which have high pharmacological activity, and on experimental studies of the acquired compounds.

Clinical trials are conducted with the active participation of the Research Institute of Experimental Medicine, Military-Medical Academy, the I.P. Pavlov St. Petersburg State Medical University, the Medical Academy of Postgraduate Education, the Research Institute of Children's Infections, and the Veterinary Academy.

The CytoNIR Company is willing to cooperate with researchers who have interesting and promising ideas in the field of medicine and pharmacology.

STRATEGIC RESEARCH ACTIVITIES IN THE DEVELOPMENT OF NEW PEPTIDE MEDICINAL MEDICATIONS

Development of medical products for prophylaxis and correction of ecologically induced secondary immunity-deficient conditions

Development of medical products for prophylaxis and treatment of urological and andrological diseases

Development of medical products for prophylaxis and treatment of disturbances in lipid and carbohydrate metabolism

Development of medical products for prophylaxis and treatment of neuro-degenerative diseases and mental disorders

Development of medical products for prophylaxis and treatment of allergic illnesses

Development of medical products for prophylaxis and treatment of viral diseases

Development of medical products for prophylaxis and treatment of reparative conditions

Company News

Cytomed is building a new pharmaceutical complex in the Lappeenrant region

In May 2012, Cytomed is planning to complete construction and equipment installment in the pharmaceutical plant